Alnylam Pharmaceuticals Inc at SVB Leerink Global Healthcare (Virtual) Transcript
Good morning, next session of this year's GHC. I'm Mani Foroohar, Senior Analyst for Genetic Medicines. And at point I'm hosting Jeff Poulton, CFO of Alnylam. Jeff, how you're doing?
Good. Good to be here with you today, Mani.
Questions & Answers
Great to have you. Those investing audience for the 100th time, I'm sure you guys have -- after 2 years, you guys are familiar with this as I am. The question you want to send in, of course, you can type in the interface right below my chin on the screen right now. And I'll go ahead and pass it along to Jeff.
But I'll start with one of my own. Obviously, there's a lot of squabbling about my TTR study, your TTR study and a lot of confusion about how they're going to behave.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
